Bladder Cancer

Bladder Cancer

HER2-Directed Strategies in Urothelial Cancer, featuring Dr. Miles Hsu and Dr. Brendan Guercio discussing innovative treatments for bladder cancer, with a cityscape background.

Bladder Cancer

03/15/2026

Novel HER2–Targeting Therapies in Urothelial Cancer

Miles Hsu, MDBrendan Guercio, MD
Researchers Brendan Guercio, MD, and Andrea Apolo, MD, discuss circulating tumor DNA for guiding muscle-invasive bladder cancer treatment, with a cityscape background.

Bladder Cancer

03/13/2026

Circulating Tumor DNA to Guide Treatment in Muscle-Invasive Bladder Cancer

Brendan Guercio, MDAndrea Apolo, MD
EV Plus Pembro improves outcomes in muscle-invasive bladder cancer in KEYNOTE-B15/EV-304, featuring researchers Rohit Gosain, MD, and Rahul Gosain, MD, MBA, with a cityscape background.

Bladder Cancer

03/10/2026

Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes in Muscle-Invasive Bladder Cancer in KEYNOTE-B15/EV-304

Rahul Gosain, MD, MBARohit Gosain, MD
Efficacy of Enfortumab Vedotin and Pembrolizumab in muscle-invasive bladder cancer treatment, featuring experts Elias Chandran and Vishesh Khanna against a cityscape background.

Bladder Cancer

03/09/2026

Enfortumab Vedotin-Pembrolizumab’s Role in Muscle-Invasive Bladder Cancer Treatment

Elias Chandran, MBBS, FRACPVishesh Khanna, MD
Evolving treatment strategies in bladder cancer research presented by OncUpdates, featuring medical professionals discussing innovative therapies and recent advancements in bladder cancer management.

Bladder Cancer

03/09/2026

Insights from ASCO GU 2026: Evolving Treatment Strategies in Bladder Cancer

Zeynep Irem Ozay, MD
Enhanced immunotherapy plus BCG treatment for high-risk non-muscle invasive bladder cancer; two doctors in formal attire with cityscape background.

Bladder Cancer

03/08/2026

Immunotherapy Plus BCG Shows Promise in NMIBC: Insights From POTOMAC and CREST

Ashish M. Kamat, MD, MBBS, FACSVishesh Khanna, MD